Investor Presentaiton slide image

Investor Presentaiton

Growth Catalysts • • PLASMA PROTEINS Ongoing robust demand Commercialization of 5 global product launches Grow China business • R&D pipeline - CVD, Fc Multimer, transplant, gene therapy Outperformance Drivers INNOVATION INFLUENZA • • Product differentiation - FLUCELVAX® • Sales shifting towards FLUADⓇ and QIV EFFICIENCY & FLEXIBILITY Harness benefits from new technology investments Significant manufacturing capacity expansion EFFICIENCY * FLEXIBILITY • Opening 40 collection centres in FY20 18 | Driven by Our Promise™ CSL
View entire presentation